Ocular Delivery of Therapeutic Proteins: A Review
Therapeutic proteins, including monoclonal antibodies, single chain variable fragment (ScFv), crystallizable fragment (Fc), and fragment antigen binding (Fab), have accounted for one-third of all drugs on the world market. In particular, these medicines have been widely used in ocular therapies in t...
Main Authors: | Divyesh H. Shastri, Ana Catarina Silva, Hugo Almeida |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/205 |
Similar Items
-
Overview of Recent Advances in Nano-Based Ocular Drug Delivery
by: Li-Ching Liu, et al.
Published: (2023-10-01) -
Polysaccharide-based nanogels and ocular drug delivery: The emerging nanocarrier for crossing blood retinal barrier
by: Dharmeshkumar M. Modi, et al.
Published: (2023-12-01) -
An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization
by: Zhang C, et al.
Published: (2022-10-01) -
Niosomal Drug Delivery Systems for Ocular Disease—Recent Advances and Future Prospects
by: Saliha Durak, et al.
Published: (2020-06-01) -
Nanotechnology-based strategies for treatment of ocular disease
by: Yuhua Weng, et al.
Published: (2017-05-01)